111.50
-2.00
(-1.76%)
At close: 1:30:03 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
831,360.00
712,988.00
557,348.00
505,539.00
466,881.00
Cost of Revenue
209,662.00
200,494.00
185,481.00
163,703.00
123,604.00
Gross Profit
621,698.00
512,494.00
371,867.00
341,836.00
343,277.00
Operating Expense
372,595.00
312,856.00
237,256.00
219,894.00
196,640.00
Operating Income
249,103.00
199,638.00
134,611.00
121,942.00
146,637.00
Net Non Operating Interest Income Expense
13,569.00
6,677.00
-1,574.00
-5,435.00
-5,547.00
Pretax Income
262,180.00
209,997.00
173,550.00
116,055.00
152,488.00
Tax Provision
46,163.00
32,097.00
31,834.00
14,335.00
24,483.00
Net Income Common Stockholders
216,017.00
177,900.00
141,716.00
101,720.00
128,005.00
Diluted NI Available to Com Stockholders
216,017.00
177,900.00
141,716.00
101,720.00
128,005.00
Basic EPS
3.16
2.66
2.14
1.54
1.93
Diluted EPS
2.95
2.41
1.92
1.51
1.89
Basic Average Shares
68,244.29
66,847.00
66,190.00
66,190.00
66,190.00
Diluted Average Shares
76,181.00
76,442.00
74,658.00
70,978.00
70,546.00
Total Expenses
582,257.00
513,350.00
422,737.00
383,597.00
320,244.00
Net Income from Continuing & Discontinued Operation
216,017.00
177,900.00
141,716.00
101,720.00
128,005.00
Normalized Income
216,017.00
177,900.00
141,716.00
101,832.19
129,637.72
Interest Income
19,655.00
14,897.00
4,884.00
2,631.00
1,920.00
Interest Expense
6,086.00
8,220.00
6,458.00
8,066.00
7,467.00
Net Interest Income
13,569.00
6,677.00
-1,574.00
-5,435.00
-5,547.00
EBIT
268,266.00
218,217.00
180,008.00
124,121.00
159,955.00
EBITDA
331,489.00
281,348.00
242,066.00
177,144.00
175,264.00
Reconciled Cost of Revenue
209,662.00
200,494.00
185,481.00
163,703.00
123,604.00
Reconciled Depreciation
63,223.00
63,131.00
62,058.00
53,023.00
15,309.00
Net Income from Continuing Operation Net Minority Interest
216,017.00
177,900.00
141,716.00
101,720.00
128,005.00
Total Unusual Items Excluding Goodwill
--
--
3,782.00
-128.00
-1,945.00
Total Unusual Items
--
--
3,782.00
-128.00
-1,945.00
Normalized EBITDA
331,489.00
281,348.00
242,066.00
177,272.00
177,209.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-15.81
-312.28
12/31/2020 - 3/12/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1783.TW Maxigen Biotech Inc.
49.30
-5.37%
6782.TW Visco Vision Inc.
158.50
-2.46%
6491.TW Pegavision Corporation
357.00
+0.14%
1752.TW Nang Kuang Pharmaceutical Co., Ltd.
41.35
-0.24%
4771.TW Vizionfocus Inc.
161.00
-0.62%
6612.TWO ICARES Medicus, Inc.
117.50
-2.08%
1565.TWO St.Shine Optical Co.,Ltd.
188.00
-1.57%
4111.TWO Chi Sheng Pharma & Biotech Co., Ltd
28.50
-0.70%
9103.TW Medtecs International Corporation Limited
6.27
+0.16%
4107.TWO Bioteque Corporation
121.50
0.00%